Published September 2017 | Version v1
Journal article

Developing new PET tracers to image the growth hormone secretagogue receptor 1a (GHS-R1a)

  • 1. Department of Radiopharmaceuticals Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba 263-8555 (Japan)

Description

The growth hormone secretagogue receptor 1a (GHS-R1a) is the orphan G-protein-coupled receptor, and its endogenous ligand is ghrelin. GHS-R1a contributes to regulation of glucose homeostasis, memory and learning, food addiction, and neuroprotection. Several PET tracers for GHS-R1a have been developed, but none have been reported to be clinically applicable to GHS-R1a imaging. In this study, we developed three new PET tracers for GHS-R1a: 18F-labeled 6-(4-chlorophenyl)-3-((1-(2-fluoroethyl)piperidin-3-yl)methyl)-2-(o-tolyl)quinazolin-4(3H)-one (1), 11C-labeled 6-(4-chlorophenyl)-3-((1-(2-methoxyethyl)piperidin-3-yl)methyl)-2-(o-tolyl)quinazolin-4(3H)-one (2), and 11C-labeled (S)-(4-(1H-indole-6-carbonyl)-3-methylpiperazin-1-yl)(4′-methoxy-[1,1′-biphenyl]-4-yl)methanone (3).

Availability note (English)

Available from http://dx.doi.org/10.1016/j.nucmedbio.2017.06.002

Additional details

Identifiers

DOI
10.1016/j.nucmedbio.2017.06.002;
PII
S096980511730080X;

Publishing Information

Journal Title
Nuclear Medicine and Biology
Journal Volume
52
Journal Page Range
p. 49-56
ISSN
0969-8051
CODEN
NMBIEO

Optional Information

Copyright
Copyright (c) 2017 Elsevier Inc. All rights reserved.